Clinical trial
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
NCT00319878 · Office of Rare Diseases (ORD), NIH · Unknown status
Key facts
| NCT number | NCT00319878 |
|---|---|
| Title | Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia |
| Official title | A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia |
| Lead sponsor | Office of Rare Diseases (ORD), NIH |
| Collaborators | Rare Diseases Clinical Research Network |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Aplastic |
| Intervention type | Drug |
| Interventions | Sirolimus, Cyclosporine |
| Enrollment | 52 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Apr 27, 2006 |
| Last update posted | Oct 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: